Error: Could not add to watchlist. X

Biogen Inc

+ Watchlist
BIIB:US
NASDAQ GS
303.69
USD
0.80
0.26%
As of 20:10:00 ET on 08/28/2015.
Open
301.00
Day Range
299.76 - 306.45
Volume
2,059,085
Previous Close
304.49
52Wk Range
265.00 - 480.18
1 Yr Return
-11.47%
Open
301.00
Day Range
299.76 - 306.45
Volume
2,059,085
Previous Close
304.49
52Wk Range
265.00 - 480.18
1 Yr Return
-11.47%
YTD Return
-10.53%
Current P/E Ratio (TTM)
20.70
Earnings per Share (USD) (TTM)
14.67
Market Cap (b USD)
71.419
Shares Outstanding (m)
235.169
Price/Sales (TTM)
6.94
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

Profile
Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.
ADDRESS
225 Binney Street
Cambridge, MA 02142
United States
PHONE
781-464-2000
  • George A Scangos
    Chief Executive Officer
  • Susan H Alexander
    Exec VP/Chief Legal Ofcr/Secy
  • Paul J Clancy
    Exec VP:Finance/CFO
  • Stephen H Holtzman "Steve"
    Exec VP:Corporate Development
  • Stuart A Kingsley "Tony"
    Exec VP:Global Commercial Ops
Show More